Wockhardt Ltd - ESG Rating & Company Profile powered by AI
This Disclosure score covers 17 UN SDGs including: 'No Poverty', 'Decent Work & Economic Growth' and 'Life below Water'. Detailed ESG assessment of Wockhardt Ltd can be accessed by signing up for free. If you work at Wockhardt Ltd and you would like to licence your Sustainability rating, please get in touch.
Wockhardt Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Wockhardt Ltd | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Wockhardt Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Wockhardt Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Wockhardt Ltd report the average age of the workforce?
Sign up for free to unlockDoes Wockhardt Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Wockhardt Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Wockhardt Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Wockhardt Ltd offer flexible work?
Sign up for free to unlockDoes Wockhardt Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Wockhardt Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Wockhardt Ltd conduct supply chain audits?
Sign up for free to unlockDoes Wockhardt Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Wockhardt Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Wockhardt Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Wockhardt Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Wockhardt Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Wockhardt Ltd disclose water use targets?
Sign up for free to unlockDoes Wockhardt Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Wockhardt Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Wockhardt Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Wockhardt Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Wockhardt Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Wockhardt Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Wockhardt Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Wockhardt Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Wockhardt Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Wockhardt Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Wockhardt Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Wockhardt Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Wockhardt Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Wockhardt Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Wockhardt Ltd disclose its waste policy?
Sign up for free to unlockDoes Wockhardt Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Wockhardt Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Wockhardt Ltd disclose energy use targets?
Sign up for free to unlockDoes Wockhardt Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Wockhardt Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Wockhardt Ltd
These potential risks are based on the size, segment and geographies of the company.
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. It provides pharmaceutical products in the therapeutic areas of anti-infective, cardiology, dermatology, diabetology, neurology, pain management, respiratory, and other areas. The company offers generic products that comprise injectables, including cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of anti-infectives, which include WCK 771 and WCK 2349 that is in Phase II human clinical trials for the treatment of staphylococcal infections; and WCK 5222, WCK 4282, WCK 4873, and WCK 6777 lead molecules, which are under pre-clinical trials. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited.